AUTL
Autolus Therapeutics Plc
NASDAQ · Healthcare · Biotechnology · GB
$1.59
−0.63%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 2.46x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 5.65x
- Price / sales
- 3.61x
- Price / cash flow
- -1.88x
Enterprise value
- Enterprise value
- $305.1M
- EV / sales
- 2.60x
- EV / EBITDA
- -1.38x
- EV / EBIT
- -1.23x
- Market cap
- $423.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026